GSE214306 CCM1 knockout 4 v 2 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE214306_CCM1 knockout_4_v_2_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE214306_CCM1 knockout_4_v_2_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE214306_CCM1 knockout_4_v_2_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE214306_CCM1 knockout_4_v_2_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

microtubule associated protein 7

Gene

aldo-keto reductase family 1 member C3

Gene

secreted frizzled related protein 1

Gene

argininosuccinate synthase 1

Gene

carbonic anhydrase 12

Gene

aldehyde dehydrogenase 1 family member A1

Gene

stearoyl-CoA desaturase

Gene

C-X-C motif chemokine ligand 12

Gene

solute carrier family 38 member 1

Gene

asparagine synthetase (glutamine-hydrolyzing)

  • Gene

    microtubule associated protein 7


  • Gene

    aldo-keto reductase family 1 member C3


  • Gene

    secreted frizzled related protein 1


  • Gene

    argininosuccinate synthase 1


  • Gene

    carbonic anhydrase 12


  • Gene

    aldehyde dehydrogenase 1 family member A1


  • Gene

    stearoyl-CoA desaturase


  • Gene

    C-X-C motif chemokine ligand 12


  • Gene

    solute carrier family 38 member 1


  • Gene

    asparagine synthetase (glutamine-hydrolyzing)

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.